Cigna Group
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Earnings Per Share
Note 5 – Earnings Per Share
Basic and diluted earnings per share were computed as follows:
| Three Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| September 30, 2026 · September 30, 2025 | |||||||||||
| (Shares in thousands, dollars in millions, except per share amounts) · Basic · Effect ofDilution · Diluted · Basic · Effect ofDilution · Diluted | |||||||||||
| Shareholders' net income | $1,442 | $1,442 | $1,868 | $1,868 | |||||||
| Shares: | |||||||||||
| Weighted average | 262,790 | 262,790 | 265,913 | 265,913 | |||||||
| Common stock equivalents | 998 | 998 | 1,617 | 1,617 | |||||||
| Total shares | 262,790 | 998 | 263,788 | 265,913 | 1,617 | 267,530 | |||||
| Earnings per share | $5.49 | $(0.02) | $5.47 | $7.02 | $(0.04) | $6.98 | |||||
| Nine Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| September 30, 2026 · September 30, 2025 | |||||||||||
| (Shares in thousands, dollars in millions, except per share amounts) · Basic · Effect ofDilution · Diluted · Basic · Effect ofDilution · Diluted | |||||||||||
| Shareholders' net income | $4,756 | $4,756 | $4,723 | $4,723 | |||||||
| Shares: | |||||||||||
| Weighted average | 262,841 | 262,841 | 267,635 | 267,635 | |||||||
| Common stock equivalents | 1,082 | 1,082 | 1,892 | 1,892 | |||||||
| Total shares | 262,841 | 1,082 | 263,923 | 267,635 | 1,892 | 269,527 | |||||
| Earnings per share | $18.09 | $(0.07) | $18.02 | $17.65 | $(0.13) | $17.52 | |||||
The following outstanding employee stock options were not included in the computation of diluted earnings per share because their effect was anti-dilutive:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In millions) | 2026 | 2025 | 2026 | 2025 |
| Anti-dilutive options | 2.1 | 2.1 | 2.2 | 1.9 |
On October 28, 2026, the Board of Directors of The Cigna Group (the "Board") declared the fourth quarter cash dividend of $1.56 per share of The Cigna Group common stock to be paid on December 17, 2026 to shareholders of record on December 3, 2026. The Company currently intends to pay regular quarterly dividends, with future declarations subject to approval by the Board and the Board's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders. The decision of whether to pay future dividends and the amount of any such dividends will be based on the Company's financial position, results of operations, cash flows, capital requirements, the requirements of applicable law and any other factors the Board may deem relevant.
The Company held approximately 143.2 million shares of common stock in treasury as of September 30, 2026,141.1 million shares as of December 31, 2025 and 137.4 million shares as of September 30, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.